Kerry Need

About Kerry Need

Biopharmaceutical executive with leadership experience across oncology, immunology, and neuroscience. Combines commercial launch expertise with global clinical program leadership, driving indication expansion, lifecycle growth, and complex alliance strategy across large pharma and biotech environments. Known for building cross-functional teams that deliver sustained results. & :• : Led cross-functional strategy development & execution for multiple oncology assets through pivotal data readouts, FDA submissions, and global regulatory filings, securing approvals across the US, EU, Japan, and additional territories while advancing key therapies into earlier-line settings.• & : Drove flagship oncology brand growth to become standard-of-care, achieving sustained revenue expansion through strategic lifecycle decisions & disciplined commercial strategy.• : Directed high-profile immunology launches, introducing new therapies into hyper-competitive markets and earning recognition for business impact and execution excellence. & :• : Recruited to lead marketing for a large commercial franchise and later entrusted with rebuilding and guiding a challenged global program team through major organizational transition.• : Built and led global brand strategies across oncology, hematology-oncology, and immunology, overseeing launches, portfolio positioning, and long-term growth planning.• & : Managed complex global alliances across co-development and commercialization structures, aligning governance, strategy, and execution at both program and enterprise levels. & :• : Rebuilt team cohesion during periods of significant change, delivering strategic milestones while maintaining high engagement and performance.• : Invests authentically in talent development, cultivating cross-functional teams capable of sustained execution and long-term organizational success.

Experience

1. Executive Director, Product Team Lead

   Pfizer

   Jan 2020 — Present · Seattle, WA, US

   Joined Seagen as Senior Director of Marketing leading the ADCETRIS commercial team, advanced to Executive Director and Global Product Team Leader, and continued in role following Pfizer’s acquisition. Lead global cross-functional strategy across clinical development, regulatory, commercial, and alliance management for multiple oncology programs while managing complex global partnerships and enterprise governance.• & : Expanded ADCETRIS into a near blockbuster franchise to become standard-of-care by aligning commercial, medical, and clinical strategy, driving sustained growth and competitive differentiation.• : Led multiple oncology assets through pivotal data readouts, global disclosures, and regulatory submissions, securing accelerated approvals across major markets and advancing additional indications into earlier-line settings.• & : Redesigned alliance structures and governance models to align development and commercial priorities, while expanding assets into new tumor types and earlier lines of therapy to strengthen lifecycle value.• : Guided strategic planning and key program decisions for a novel EGFR-directed bispecific T-cell engager with potential across multiple tumor types.• & : Introduced artificial intelligence capabilities to mine clinical and preclinical datasets, to uncover new clinical and commercial lifecycle opportunities.• & : Re-energized & restored strategic focus to stalled global program team, maintained performance through acquisition integration, and championed culture-building initiatives to strengthen talent retention & engagement.

Education

• Purdue University

  B.S., Chemical Engineering

• Harvard Medical School

  Other; HMX Fundamentals/Pro online certificate program – Immunology

• Harvard Business School

  MBA

Skills

• Global Marketing
• Leadership
• Biotechnology
• Management
• Strategy
• Pharmaceutical Sales
• Lifesciences
• Oncology
• Biopharmaceuticals
• Pharmaceutical Industry
• Fda
• Forecasting
• Product Launch
• Project Management
• Cross-Functional Team Leadership
• Commercialization
• Start-Ups
• Validation
• Market Analysis